These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24509894)

  • 1. Oxytocin nasal spray in fibromyalgic patients.
    Mameli S; Pisanu GM; Sardo S; Marchi A; Pili A; Carboni M; Minerba L; Trincas G; Carta MG; Melis MR; Agabio R
    Rheumatol Int; 2014 Aug; 34(8):1047-52. PubMed ID: 24509894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a placebo-controlled, within-participants crossover trial evaluating the efficacy of intranasal oxytocin to improve pain and function among women with chronic pelvic musculoskeletal pain.
    Rash JA; Toivonen K; Robert M; Nasr-Esfahani M; Jarrell JF; Campbell TS
    BMJ Open; 2017 Apr; 7(4):e014909. PubMed ID: 28416501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal oxytocin and NSAIDs : Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. 2014 Aug;34(8):1047-52.).
    Kwong KK; Chan ST
    Rheumatol Int; 2015 May; 35(5):941-2. PubMed ID: 25354464
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxytocin nasal spray in fibromyalgic patients: additional information : reply to the comment to the editor entitled "future directions for the investigation of intranasal oxytocin and pain".
    Agabio R; Mameli S; Sardo S; Minerba L; Melis MR
    Rheumatol Int; 2014 Sep; 34(9):1335-6. PubMed ID: 25070143
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of vitamin D replacement therapy on patients with chronic nonspecific widespread musculoskeletal pain with vitamin D deficiency.
    Yilmaz R; Salli A; Cingoz HT; Kucuksen S; Ugurlu H
    Int J Rheum Dis; 2016 Dec; 19(12):1255-1262. PubMed ID: 27860257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future directions for the investigation of intranasal oxytocin and pain: Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. E-pub ahead of print. doi: 10.1007/s00296-014-2953-y).
    Rash JA; Campbell TS
    Rheumatol Int; 2014 Aug; 34(8):1177-8. PubMed ID: 24939559
    [No Abstract]   [Full Text] [Related]  

  • 7. Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study.
    Bruno A; Micò U; Lorusso S; Cogliandro N; Pandolfo G; Caminiti M; Zoccali RA; Muscatello MR
    J Clin Psychopharmacol; 2013 Aug; 33(4):507-11. PubMed ID: 23764682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Men's sexual response to female partner's intranasal oxytocin administration for hypoactive sexual desire disorder: an open prospective cohort study.
    Muin DA; Sheikh Rezaei S; Tremmel-Scheinost M; Salama M; Luger A; Wolzt M; Husslein PW; Bayerle-Eder M
    Fertil Steril; 2017 Mar; 107(3):781-787.e3. PubMed ID: 28189292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial.
    Muin DA; Wolzt M; Marculescu R; Sheikh Rezaei S; Salama M; Fuchs C; Luger A; Bragagna E; Litschauer B; Bayerle-Eder M
    Fertil Steril; 2015 Sep; 104(3):715-23.e4. PubMed ID: 26151620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
    Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    Arthritis Res Ther; 2011 Jun; 13(3):R86. PubMed ID: 21668963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.
    Rossini M; Di Munno O; Valentini G; Bianchi G; Biasi G; Cacace E; Malesci D; La Montagna G; Viapiana O; Adami S
    Clin Exp Rheumatol; 2007; 25(2):182-8. PubMed ID: 17543140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
    Arnold LM; Leon T; Whalen E; Barrett J
    Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-level laser therapy on pain, quality of life and sleep in patients with fibromyalgia: study protocol for a double-blinded randomized controlled trial.
    de Carvalho Pde T; Leal-Junior EC; Alves AC; Rambo CS; Sampaio LM; Oliveira CS; Albertini R; de Oliveira LV
    Trials; 2012 Nov; 13():221. PubMed ID: 23171567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
    Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
    Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia.
    Arnold LM; Crofford LJ; Martin SA; Young JP; Sharma U
    Pain Med; 2007; 8(8):633-8. PubMed ID: 18028041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intranasal oxytocin administration on acute cold pressor pain: a placebo-controlled, double-blind, within-participants crossover investigation.
    Rash JA; Campbell TS
    Psychosom Med; 2014; 76(6):422-9. PubMed ID: 24979580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in clinical outcomes after dry needling versus myofascial release on pain pressure thresholds, quality of life, fatigue, pain intensity, quality of sleep, anxiety, and depression in patients with fibromyalgia syndrome.
    Castro Sánchez AM; García López H; Fernández Sánchez M; Pérez Mármol JM; Aguilar-Ferrándiz ME; Luque Suárez A; Matarán Peñarrocha GA
    Disabil Rehabil; 2019 Sep; 41(19):2235-2246. PubMed ID: 29681188
    [No Abstract]   [Full Text] [Related]  

  • 20. No side-effects of single intranasal oxytocin administration in middle childhood.
    Verhees MWFT; Houben J; Ceulemans E; Bakermans-Kranenburg MJ; van IJzendoorn MH; Bosmans G
    Psychopharmacology (Berl); 2018 Aug; 235(8):2471-2477. PubMed ID: 29915962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.